Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1995 Feb;87(2):113–118.

Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.

O O Oyelola 1, A A Ajayi 1, R O Babalola 1, E A Stein 1
PMCID: PMC2607772  PMID: 7897682

Abstract

Plasma lipids, lipoproteins, and apolipoproteins were assessed in three groups of Nigerians at increased risk for atherosclerotic heart disease. The three patient groups, diabetes mellitus (n = 15), essential hypertension (n = 12), and hypertensive-diabetes mellitus (n = 11), were compared with age-matched, apparently healthy controls (n = 14). In subjects with diabetes mellitus, triglyceride and its related apolipoproteins CIII and CIII:NonB were significantly higher than controls. High-density lipoprotein cholesterol (HDL-C) was significantly lower; its related ratios, total/HDL-C and low-density lipoprotein cholesterol (LDL-C)/HDL-C were significantly higher than those for controls. Subjects with hypertension and hypertensive-diabetes mellitus had significantly higher values than controls for those lipids and lipid fractions considered atherogenic (total cholesterol, LDL-C, triglyceride, and the total/HDL-C and LDL-C/HDL-C ratios) as well as apolipoproteins B, CIII, and lipoprotein particles Lp(a) and CIII:NonB. Only hypertensive-diabetes mellitus subjects had lower HDL-C levels, while hypertension patients had significantly higher apolipoprotein AI and LpAI concentrations than controls. Subjects with hypertensive-diabetes mellitus had significantly worse lipid, lipoprotein, and apolipoprotein profiles both in terms of increased atherogenic and reduced anti-atherogenic parameters compared with subjects with diabetes mellitus or hypertension only. These studies suggest that Nigerians with diabetes, hypertension, and especially both hypertension and diabetes need to be fully evaluated from a lipid and lipoprotein standpoint, and any abnormalities detected need to be taken into consideration during therapy of this group of high-risk patients.

Full text

PDF
113

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assmann G., Schulte H. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J. 1988 Dec;116(6 Pt 2):1713–1724. doi: 10.1016/0002-8703(88)90220-7. [DOI] [PubMed] [Google Scholar]
  2. Butler W. J., Ostrander L. D., Jr, Carman W. J., Lamphiear D. E. Mortality from coronary heart disease in the Tecumseh study. Long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol. 1985 Apr;121(4):541–547. doi: 10.1093/oxfordjournals.aje.a114031. [DOI] [PubMed] [Google Scholar]
  3. Donahue R. P., Abbott R. D., Reed D. M., Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes. 1987 Jun;36(6):689–692. doi: 10.2337/diab.36.6.689. [DOI] [PubMed] [Google Scholar]
  4. Factor S. M., Minase T., Sonnenblick E. H. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J. 1980 Apr;99(4):446–458. doi: 10.1016/0002-8703(80)90379-8. [DOI] [PubMed] [Google Scholar]
  5. Ferrannini E., Natali A. Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J. 1991 Apr;121(4 Pt 2):1274–1282. doi: 10.1016/0002-8703(91)90433-i. [DOI] [PubMed] [Google Scholar]
  6. Gordon T., Garcia-Palmieri M. R., Kagan A., Kannel W. B., Schiffman J. Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico. J Chronic Dis. 1974 Sep;27(7-8):329–344. doi: 10.1016/0021-9681(74)90013-7. [DOI] [PubMed] [Google Scholar]
  7. Harris M. I. Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population. Diabetes Care. 1991 May;14(5):366–374. doi: 10.2337/diacare.14.5.366. [DOI] [PubMed] [Google Scholar]
  8. Hong M. K., Romm P. A., Reagan K., Green C. E., Rackley C. E. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol. 1991 Dec 15;68(17):1646–1650. doi: 10.1016/0002-9149(91)90323-d. [DOI] [PubMed] [Google Scholar]
  9. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–2038. doi: 10.1001/jama.241.19.2035. [DOI] [PubMed] [Google Scholar]
  10. Knowler W. C., Bennett P. H., Ballintine E. J. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N Engl J Med. 1980 Mar 20;302(12):645–650. doi: 10.1056/NEJM198003203021201. [DOI] [PubMed] [Google Scholar]
  11. Knuiman J. T., West C. E. HDL cholesterol in men from thirteen countries. Lancet. 1981 Aug 15;2(8242):367–368. doi: 10.1016/s0140-6736(81)90687-5. [DOI] [PubMed] [Google Scholar]
  12. Nissinen A., Böthig S., Granroth H., Lopez A. D. Hypertension in developing countries. World Health Stat Q. 1988;41(3-4):141–154. [PubMed] [Google Scholar]
  13. Nosadini R., Crepaldi G., D'Angelo A. Diabetes mellitus and hypertension: a physiologic basis for a rational therapeutic approach. Am Heart J. 1991 Apr;121(4 Pt 2):1289–1293. doi: 10.1016/0002-8703(91)90435-k. [DOI] [PubMed] [Google Scholar]
  14. Ogunnowo P. O., Odesanmi W. O., Andy J. J. Coronary artery pathology of 111 consecutive Nigerians. Trans R Soc Trop Med Hyg. 1986;80(6):923–926. doi: 10.1016/0035-9203(86)90260-9. [DOI] [PubMed] [Google Scholar]
  15. Onitiri A. C., Sander M., Boyo A. E. Serum lipids and lipoproteins in healthy Africans. Clin Chim Acta. 1977 Nov 15;81(1):57–61. doi: 10.1016/0009-8981(77)90413-2. [DOI] [PubMed] [Google Scholar]
  16. Ostrander L. D., Jr, Lamphiear D. E., Carman W. J., Williams G. W. Blood glucose and risk of coronary heart disease. Arteriosclerosis. 1981 Jan-Feb;1(1):33–37. doi: 10.1161/01.atv.1.1.33. [DOI] [PubMed] [Google Scholar]
  17. Oyelola O. O. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives. Contraception. 1993 May;47(5):445–454. doi: 10.1016/0010-7824(93)90096-p. [DOI] [PubMed] [Google Scholar]
  18. Ross R. The pathogenesis of atherosclerosis--an update. N Engl J Med. 1986 Feb 20;314(8):488–500. doi: 10.1056/NEJM198602203140806. [DOI] [PubMed] [Google Scholar]
  19. Smith S. J., Cooper G. R., Henderson L. O., Hannon W. H. An international collaborative study on standardization of apolipoproteins A-I and B. Part I. Evaluation of a lyophilized candidate reference and calibration material. Clin Chem. 1987 Dec;33(12):2240–2249. [PubMed] [Google Scholar]
  20. States of insulin resistance: the interaction between hypertension, glucose intolerance, and coronary heart disease. Proceedings of a symposium. Montreal, Canada, June 24, 1990. Am Heart J. 1991 Apr;121(4 Pt 2):1267–1318. [PubMed] [Google Scholar]
  21. Taylor G. O., Barber J. B., Jackson M. A., Resch J. A., Williams A. O. Lipid composition of cerebral vessels in American Negroes, Caucasians and Nigerian Africans: a comparative study. Stroke. 1975 May-Jun;6(3):298–300. doi: 10.1161/01.str.6.3.298. [DOI] [PubMed] [Google Scholar]
  22. West K. M. Diabetes in American Indians and other native populations of the New World. Diabetes. 1974 Oct;23(10):841–855. doi: 10.2337/diab.23.10.841. [DOI] [PubMed] [Google Scholar]
  23. Williams A. O. Coronary atherosclerosis in Nigeria. Br Heart J. 1971 Jan;33(1):95–100. doi: 10.1136/hrt.33.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. van Hoeven K. H., Factor S. M. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation. 1990 Sep;82(3):848–855. doi: 10.1161/01.cir.82.3.848. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES